An ultra-short dopamine pathway regulates basal ganglia output.
Substantia nigra pars reticulata (SNr) is a key basal ganglia output nucleus critical for movement control. Its GABA-containing projection neurons intermingle with nigral dopamine (DA) neuron dendrites. Here we show that SNr GABA neurons coexpress dopamine D(1) and D(5) receptor mRNAs and also mRNA for TRPC3 channels. Dopamine induced an inward current in these neurons and increased their firing frequency. These effects were mimicked by D(1)-like agonists, blocked by a D(1)-like antagonist. D(1)-like receptor blockade reduced SNr GABA neuron firing frequency and increased their firing irregularity. These D(1)-like effects were absent in D(1) or D(5) receptor knock-out mice and inhibited by intracellularly applied D(1) or D(5) receptor antibody. These D(1)-like effects were also inhibited when the tonically active TRPC3 channels were inhibited by intracellularly applied TRPC3 channel antibody. Furthermore, stimulation of DA neurons induced a direct inward current in SNr GABA neurons that was sensitive to D(1)-like blockade. Manipulation of DA neuron activity and DA release and inhibition of dopamine reuptake affected SNr GABA neuron activity in a D(1)-like receptor-dependent manner. Together, our findings indicate that dendritically released dopamine tonically excites SNr GABA neurons via D(1)-D(5) receptor coactivation that enhances constitutively active TRPC3 channels, forming an ultra-short substantia nigra pars compacta --> SNr dopamine pathway that regulates the firing intensity and pattern of these basal ganglia output neurons.
Zhou
Fu-Wen
FW
Department of Pharmacology, University of Tennessee College of Medicine, Memphis, TN 38163, USA. fzhou3@utmem.edu
Jin
Ying
Y
Matta
Shannon G
SG
Xu
Ming
M
Zhou
Fu-Ming
FM
D000818:Animals; D001479:Basal Ganglia / Q000187:drug effects / Q000502:physiology*; D004298:Dopamine / Q000502:physiology*; D018491:Dopamine Agonists / Q000494:pharmacology; D005260:Female; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D009434:Neural Pathways / Q000187:drug effects / Q000502:physiology; D011954:Receptors, Dopamine / Q000502:physiology; D015398:Signal Transduction / Q000502:physiology*
D018491:Dopamine Agonists; D011954:Receptors, Dopamine; D004298:Dopamine
J Neurosci. 1997 Aug 1;17(15):5738-46
9221772
J Comp Neurol. 2000 May 22;421(1):107-35
10813775
J Biol Chem. 1995 Aug 25;270(34):20073-7
7650024
J Recept Signal Transduct Res. 2004 Aug;24(3):165-205
15521361
Nature. 1980 May 22;285(5762):240-1
7374778
J Physiol. 2007 Jan 1;578(Pt 1):9-24
16990401
J Neurosci. 2009 May 20;29(20):6568-79
19458227
J Neurosci. 2007 May 9;27(19):5179-89
17494704
J Neurophysiol. 1995 Dec;74(6):2366-78
8747199
J Neurosci. 1999 Jul 1;19(13):5586-96
10377365
J Neurosci. 2008 Jan 9;28(2):473-82
18184790
J Neurophysiol. 2001 Apr;85(4):1761-71
11287497
Trends Neurosci. 2000 Oct;23(10 Suppl):S20-7
11052216
Trends Neurosci. 2000 Oct;23(10 Suppl):S8-19
11052215
J Neurosci. 2003 Jul 16;23(15):6245-54
12867509
Exp Brain Res. 1999 Apr;125(4):397-409
10323285
Cell Tissue Res. 2004 Oct;318(1):107-14
15338269
J Neurosci. 2002 Dec 15;22(24):10801-10
12486173
Nature. 1981 Feb 12;289(5798):537-42
6258083
J Neurosci. 2003 Jun 15;23(12):5079-87
12832531
Cell. 1994 Nov 18;79(4):729-42
7954836
J Neurosci. 1995 Apr;15(4):3092-103
7722648
Brain Res. 1975 Jan 17;83(3):531-7
1111820
Nature. 1976 Mar 18;260(5548):258-60
1256567
J Neurosci. 2003 Jun 15;23(12):5247-57
12832549
J Gen Physiol. 2005 Sep;126(3):243-62
16129772
J Neurophysiol. 2006 Sep;96(3):1581-91
16738217
Science. 2001 Sep 28;293(5539):2465-70
11577238
J Neurosci. 2007 Jun 13;27(24):6531-41
17567814
Science. 1983 Apr 8;220(4593):218-21
6828891
Exp Brain Res. 2005 Oct;166(2):230-6
16082534
J Neurophysiol. 1983 May;49(5):1230-53
6864248
Nat Neurosci. 2004 Apr;7(4):341-6
14990933
J Comp Neurol. 1996 Jun 03;369(3):361-71
8743418
Neuron. 2004 Jun 24;42(6):939-46
15207238
Neuroscience. 1992;46(4):959-71
1531866
J Neurochem. 2006 Jan;96(1):267-82
16300629
J Chem Neuroanat. 2003 Dec;26(4):317-30
14729134
J Neurosci. 1996 Oct 15;16(20):6579-91
8815934
J Neurosci. 1998 May 15;18(10):3548-53
9570786
Proc Natl Acad Sci U S A. 1993 Oct 1;90(19):8861-5
8415621
Neuron. 2008 Aug 14;59(3):392-8
18701065
Neuroscience. 2000;100(4):689-99
11036203
J Neurophysiol. 2004 Oct;92(4):1973-81
15115785
Neuroscience. 1997 Jul;79(2):323-7
9200717
Eur J Pharmacol. 1989 Jul 4;166(1):111-3
2572425
EMBO J. 2008 Nov 5;27(21):2809-16
18923420
J Biol Chem. 2004 Apr 2;279(14):13317-32
14699161
Trends Pharmacol Sci. 2007 Nov;28(11):551-5
17950471
Physiol Rev. 2000 Jul;80(3):953-78
10893428
Nature. 2003 Dec 4;426(6966):517-24
14654832
J Neurophysiol. 2007 Apr;97(4):2627-41
17215512
J Neurophysiol. 2006 Mar;95(3):1800-11
16306171
J Physiol. 2006 Jan 1;570(Pt 1):45-51
16195316
Brain Res Rev. 2008 Aug;58(2):303-13
18433875
J Neurophysiol. 1986 Apr;55(4):660-77
3701399
J Neurophysiol. 2002 Mar;87(3):1234-43
11877497
Arch Neurol. 2007 Jan;64(1):20-4
17210805
J Neurosci. 2001 Oct 1;21(19):7841-7
11567075
Am J Physiol Cell Physiol. 2008 Nov;295(5):C1376-84
18799650
Annu Rev Biochem. 2007;76:387-417
17579562
J Pharmacol Exp Ther. 1994 Dec;271(3):1181-92
7996424
J Neurosci. 2005 Sep 7;25(36):8272-81
16148235
Brain Res Mol Brain Res. 1995 Jul;31(1-2):86-94
7476036
Nature. 2007 Jun 28;447(7148):1081-6
17558391
Trends Neurosci. 2005 Aug;28(8):401-7
15982753
J Physiol. 2006 Mar 1;571(Pt 2):361-9
16396924
J Physiol. 1987 Nov;392:397-416
2451725
J Neurosci. 1998 Jul 15;18(14):5180-90
9651201
Nature. 1993 Nov 25;366(6453):344-7
8247128
J Neurophysiol. 2007 Sep;98(3):1489-500
17634344
J Neurosci. 1998 Aug 1;18(15):5575-85
9671649
Eur J Neurosci. 2006 Sep;24(5):1385-94
16987223